Ipca Laboratories Ltd.

NSE: IPCALAB | BSE: 524494 | ISIN: INE571A01038 | Industry: Pharmaceuticals
| Expensive Performer
1433.2500 -13.50 (-0.93%)
NSE Mar 26, 2025 15:31 PM
Volume: 153.1K
 

1433.25
-0.93%
Sharekhan
Quarterly revenues reached Rs. 2,355 crore, marking a 16% y-o-y increase and a 13% rise from the
previous quarter. Profit after tax (PAT) came in strong at Rs. 245 crore, up 39% as compared to last year and 23%, sequentially.
Number of FII/FPI investors increased from 268 to 282 in Dec 2024 qtr.
More from Ipca Laboratories Ltd.
Recommended